IL137954A0 - Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia - Google Patents

Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia

Info

Publication number
IL137954A0
IL137954A0 IL13795499A IL13795499A IL137954A0 IL 137954 A0 IL137954 A0 IL 137954A0 IL 13795499 A IL13795499 A IL 13795499A IL 13795499 A IL13795499 A IL 13795499A IL 137954 A0 IL137954 A0 IL 137954A0
Authority
IL
Israel
Prior art keywords
treatment
benign prostatic
prostatic hyperplasia
novel substituted
substituted pyridino
Prior art date
Application number
IL13795499A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of IL137954A0 publication Critical patent/IL137954A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13795499A 1998-02-20 1999-02-19 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia IL137954A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7532198P 1998-02-20 1998-02-20
PCT/US1999/003608 WO1999042448A1 (en) 1998-02-20 1999-02-19 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia

Publications (1)

Publication Number Publication Date
IL137954A0 true IL137954A0 (en) 2001-10-31

Family

ID=22124955

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13795499A IL137954A0 (en) 1998-02-20 1999-02-19 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
IL137954A IL137954A (en) 1998-02-20 2000-08-18 Converted pyridino-aripiprazines that are effective in treating the rest of the non-cancerous cell culture in the prostate

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL137954A IL137954A (en) 1998-02-20 2000-08-18 Converted pyridino-aripiprazines that are effective in treating the rest of the non-cancerous cell culture in the prostate

Country Status (24)

Country Link
US (1) US6218396B1 (hu)
EP (1) EP1054868B1 (hu)
JP (1) JP2002503724A (hu)
KR (1) KR100591028B1 (hu)
CN (1) CN1121390C (hu)
AR (1) AR014626A1 (hu)
AT (1) ATE250580T1 (hu)
AU (1) AU766398B2 (hu)
BR (1) BR9909647A (hu)
CZ (1) CZ294136B6 (hu)
DE (1) DE69911582T2 (hu)
DK (1) DK1054868T3 (hu)
ES (1) ES2209468T3 (hu)
HK (1) HK1030776A1 (hu)
HU (1) HUP0100781A3 (hu)
IL (2) IL137954A0 (hu)
NO (1) NO317103B1 (hu)
NZ (1) NZ506462A (hu)
PL (1) PL342339A1 (hu)
PT (1) PT1054868E (hu)
TR (1) TR200003220T2 (hu)
TW (1) TW565555B (hu)
WO (1) WO1999042448A1 (hu)
ZA (1) ZA991315B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69818255T2 (de) * 1997-05-12 2004-12-23 Ortho-Mcneil Pharmaceutical, Inc. Arylsubstituierte piperazine die bei der behandlung von gutartiger prostatischer hyperlasie nützlich sind
EP1311482B1 (en) 2000-08-08 2007-02-21 Ortho-McNeil Pharmaceutical, Inc. Non-imidazole aryloxypiperidines as h3 receptor ligands
US7132547B2 (en) 2001-12-28 2006-11-07 Takeda Pharmaceutical Company Limited Preventives/remedies for urinary disturbance
US8470859B2 (en) 2006-10-23 2013-06-25 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
NZ588909A (en) * 2008-04-23 2012-08-31 Takeda Pharmaceutical Iminopyridine derivatives and use thereof
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
CN103980195A (zh) * 2014-04-28 2014-08-13 广州医科大学 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用
CN108530391B (zh) * 2018-05-17 2022-05-17 袁牧 一种酰胺类芳基哌嗪衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2027898A6 (es) * 1991-01-24 1992-06-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina.
US5403847A (en) 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
WO1999003833A1 (en) * 1997-07-15 1999-01-28 Sankyo Company, Limited Piperazine derivatives

Also Published As

Publication number Publication date
NZ506462A (en) 2003-07-25
PT1054868E (pt) 2004-01-30
TR200003220T2 (tr) 2001-04-20
KR100591028B1 (ko) 2006-06-22
US6218396B1 (en) 2001-04-17
ES2209468T3 (es) 2004-06-16
BR9909647A (pt) 2000-11-21
EP1054868A1 (en) 2000-11-29
ZA991315B (en) 2000-11-20
AU3302599A (en) 1999-09-06
KR20010041115A (ko) 2001-05-15
CZ20003044A3 (cs) 2001-04-11
ATE250580T1 (de) 2003-10-15
CZ294136B6 (cs) 2004-10-13
NO20004141L (no) 2000-10-19
HUP0100781A2 (hu) 2001-08-28
AR014626A1 (es) 2001-03-28
HUP0100781A3 (en) 2002-12-28
PL342339A1 (en) 2001-06-04
IL137954A (en) 2007-06-03
AU766398B2 (en) 2003-10-16
DE69911582D1 (de) 2003-10-30
HK1030776A1 (en) 2001-05-18
CN1121390C (zh) 2003-09-17
NO20004141D0 (no) 2000-08-18
DK1054868T3 (da) 2003-12-22
JP2002503724A (ja) 2002-02-05
NO317103B1 (no) 2004-08-09
WO1999042448A1 (en) 1999-08-26
CN1291188A (zh) 2001-04-11
EP1054868B1 (en) 2003-09-24
TW565555B (en) 2003-12-11
DE69911582T2 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
NO993396L (no) Kinolin- og kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
AU1316000A (en) Compositions and methods for treating benign prostatic hyperplasia using tocotrienols
IL141235A0 (en) Combined use of an alpha-adrenoceptor antagonist and amuscarinic antagonist in the treatment of benign prostatic hyperplasi
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
AU1657097A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
EP0855910A4 (en) CONJUGATES USEFUL FOR TREATING BENIN PROSTATIC ADENOMA
IL137954A0 (en) Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
ZA983968B (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia.
ZA981781B (en) The use of levobupivacaine in treating migraine
ZA991319B (en) Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
EP1140906A4 (en) IMIDAZOLONES AND THEIR USE IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AND OTHER DISORDERS
GB9602903D0 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
EP0748627A3 (en) Melatonin agonists for the treatment of benign forms of hyperplasia of the prostate
AU2002232403A1 (en) Del-1 and benign prostatic hyperplasia
AU2002300904A1 (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
GB9810895D0 (en) Combination therapy for the treatment of benign prostatic hyperplasia
HK1045506A1 (en) Oxathiepino 6,5- i b /iÜdihydropyridines, and related compositions and methods
AU2003204320A1 (en) Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
ZA922810B (en) New combination treatment for benign prostatic hyperplasia

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed